JAK2 and neoplasm: Melanoma-derived exosomal miR-155 downregulates suppressor of cytokine signaling 1 (SOCS1), an inhibitor of the JAK2/STAT3 pathway, activating JAK2/STAT3 signaling, promoting MMP-9 expression, and enhancing tumor angiogenesis [127].